{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:59:18Z","timestamp":1792519158081,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.bmc.2022.116855","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T12:36:06Z","timestamp":1653568566000},"page":"116855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Cytotoxicity of cinchona alkaloid organocatalysts against MES-SA and MES-SA\/Dx5 multidrug-resistant uterine sarcoma cell lines"],"prefix":"10.1016","volume":"67","author":[{"given":"Szonja Polett","family":"P\u00f3sa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyula","family":"Darg\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Kissz\u00e9kelyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zs\u00f3fia","family":"Gar\u00e1di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilla","family":"H\u00e1mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Szak\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef","family":"Kupai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szil\u00e1rd","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2022.116855_b0005","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1055\/s-0029-1218699","article-title":"Hiemstra Cinchona Alkaloids in Asymmetric Organocatalysis","volume":"2010","author":"Marcelli","year":"2010","journal-title":"Synthesis"},{"key":"10.1016\/j.bmc.2022.116855_b0010","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/415686a","article-title":"Medical need, scientific opportunity and the drive for antimalarial drugs","volume":"415","author":"Ridley","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2022.116855_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-10-144","article-title":"D\u2019Alessandro Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria","volume":"10","author":"Achan","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.bmc.2022.116855_b0020","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1161\/01.CIR.92.10.2944","article-title":"Lou Koshman Antiarrhythmic activity of quinine in humans","volume":"92","author":"Sheldon","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.bmc.2022.116855_b0025","doi-asserted-by":"crossref","unstructured":"S. Malakar, L. Sreelatha, T. Dechtawewat, S. Noisakran, P. thai Yenchitsomanus, J.J.H. Chu, T. Limjindaporn Drug repurposing of quinine as antiviral against dengue virus infection. Virus Res. 2018, 255, 171\u2013178. https:\/\/doi.org\/10.1016\/j.virusres.2018.07.018.","DOI":"10.1016\/j.virusres.2018.07.018"},{"key":"10.1016\/j.bmc.2022.116855_b0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jdermsci.2007.05.009","article-title":"Donnarumma Antiviral effects of quinine sulfate on HSV-1 HaCat cells infected: Analysis of the molecular mechanisms involved","volume":"47","author":"Baroni","year":"2007","journal-title":"J. Dermatological Sci."},{"key":"10.1016\/j.bmc.2022.116855_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-0711-1-5","article-title":"Ruocco Quinine sulfate and bacterial invasion","volume":"1","author":"Wolf","year":"2002","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.bmc.2022.116855_b0040","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1039\/C5MD00515A","article-title":"Triola Squaramides with cytotoxic activity against human gastric carcinoma cells HGC-27: Synthesis and mechanism of action","volume":"7","author":"Quintana","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmc.2022.116855_b0045","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/cbdd.13346","article-title":"Steverding Cytotoxic and trypanocidal activities of cinchona alkaloid derivatives","volume":"92","author":"Kacprzak","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bmc.2022.116855_b0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/mol.108.050492","article-title":"Chmielewski Inhibition of P-glycoprotein-mediated paclitaxel resistance by reversibly linked quinine homodimers","volume":"75","author":"Pires","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bmc.2022.116855_b0055","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1016\/j.bmcl.2012.04.125","article-title":"Chmielewski Click chemistry-derived bivalent quinine inhibitors of P-glycoprotein- mediated cellular efflux. Bioorganic Med","volume":"22","author":"Kuriakose","year":"2012","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bmc.2022.116855_b0060","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1039\/C7MT00183E","article-title":"Pe\u0161i\u0107 Ferrocene-cinchona hybrids with triazolyl-chalcone linkers act as pro-oxidants and sensitize human cancer cell lines to paclitaxel","volume":"9","author":"Podolski-Reni\u0107","year":"2017","journal-title":"Metallomics"},{"key":"10.1016\/j.bmc.2022.116855_b0065","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bmcl.2010.11.127","article-title":"Celewicz Synthesis of 3\u2032-azido-3\u2032-deoxythymidine (AZT) - Cinchona alkaloid conjugates via click chemistry: Toward novel fluorescent markers and cytostatic agents. Bioorganic Med","volume":"21","author":"Baraniak","year":"2011","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bmc.2022.116855_b0070","doi-asserted-by":"crossref","first-page":"9368","DOI":"10.1002\/slct.201801810","article-title":"Wietrzyk Triazole Biheterocycles from Cinchona Alkaloids: Coordination and Antiproliferative Properties","volume":"3","author":"Boraty\u0144ski","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmc.2022.116855_b0075","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/cbdd.12523","article-title":"Huczy\u0144ski Antiproliferative Activity of Polyether Antibiotic - Cinchona Alkaloid Conjugates Obtained via Click Chemistry","volume":"86","author":"Skiera","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bmc.2022.116855_b0080","doi-asserted-by":"crossref","first-page":"25521","DOI":"10.1021\/acsami.0c01259","article-title":"Manna Quinine-Based Semisynthetic Ion Transporters with Potential Antiproliferative Activities","volume":"12","author":"Akhtar","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bmc.2022.116855_b0085","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1021\/cr4006236","article-title":"Di Pietro Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance","volume":"114","author":"Szak\u00e1cs","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bmc.2022.116855_b0090","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.2174\/092986712800167392","article-title":"Pinto Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds","volume":"19","author":"Palmeira","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bmc.2022.116855_b0095","first-page":"4225","article-title":"Qiu Nonspecifically enhanced therapeutic effects of vincristine on multidrug-resistant cancers when coencapsulated with quinine in liposomes","volume":"10","author":"Xu","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bmc.2022.116855_b0100","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1182\/blood-2002-11-3419","article-title":"Harousseau Quinine as a multidrug resistance inhibitor: A phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia","volume":"102","author":"Solary","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2022.116855_b0105","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1365-2141.1997.d01-2012.x","article-title":"Cabanillas Paclitaxel activity for the treatment of non-Hodgkin\u2019s lymphoma: Final report of a phase II trial","volume":"96","author":"Younes","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bmc.2022.116855_b0110","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0006-2952(00)00270-7","article-title":"Georges Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs","volume":"59","author":"Vezmar","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bmc.2022.116855_b0115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/bjc.1990.305","article-title":"Martin Potential usefulness of quinine to circumvent the anthracycline resistance in clinical practice","volume":"62","author":"Chauffert","year":"1990","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bmc.2022.116855_b0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1023\/A:1005716214718","article-title":"Salmon Combination chemotherapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancer","volume":"42","author":"Taylor","year":"1997","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bmc.2022.116855_b0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ijc.2910620309","article-title":"Robert Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line","volume":"62","author":"Bennis","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bmc.2022.116855_b0130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/tox.20568","article-title":"Kim Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel-induced cytotoxicity and apoptosis via multidrug resistance reversal in MES-SA\/DX5 uterine sarcoma cells","volume":"26","author":"Lee","year":"2011","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.bmc.2022.116855_b0135","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/1097-0142(19911015)68:8<1714::AID-CNCR2820680811>3.0.CO;2-2","article-title":"Guy Sufficient levels of quinine in the serum circumvent the multidrug resistance of the human leukemic cell line K562\/ADM","volume":"68","author":"Solary","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.bmc.2022.116855_b0140","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1200\/JCO.1992.10.11.1730","article-title":"Guy Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia","volume":"10","author":"Solary","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bmc.2022.116855_b0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00001813-199802000-00004","article-title":"Salmon A phase I\/II trial of paclitaxel for non-Hodgkin\u2019s lymphoma followed by paclitaxel plus quinine in drug-resistant disease","volume":"9","author":"Miller","year":"1998","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bmc.2022.116855_b0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2004.06.026","article-title":"Gottesman Predicting drug sensitivity and resistance: Profiling ABC transporter genes in cancer cells","volume":"6","author":"Szak\u00e1cs","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bmc.2022.116855_b0155","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1002\/chem.200501076","article-title":"Organocatalysis Mediated by (Thio)urea Derivatives","volume":"12","author":"Connon","year":"2006","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bmc.2022.116855_b0160","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1039\/c0cs00200c","article-title":"Jones Squaramides: physical properties, synthesis and applications","volume":"40","author":"Storer","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bmc.2022.116855_b0165","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1021\/jacs.7b01115","article-title":"Rawal Development of Chiral, Bifunctional Thiosquaramides: Enantioselective Michael Additions of Barbituric Acids to Nitroalkenes","volume":"139","author":"Rombola","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bmc.2022.116855_b0170","doi-asserted-by":"crossref","unstructured":"S. Nagy, P. Kissz\u00e9kelyi, J. Kupai Synthesis and Application of Thiosquaramides and Their Derivatives: A Review. Period. Polytech. Chem. Eng. 2018, 62, 467\u2013475\u2013467\u2013475. https:\/\/doi.org\/10.3311\/PPCH.12851.","DOI":"10.3311\/PPch.12851"},{"key":"10.1016\/j.bmc.2022.116855_b0175","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.3390\/ma12183034","article-title":"Kupai Comparison of cinchona catalysts containing ethyl or vinyl or ethynyl group at their quinuclidine ring","volume":"12","author":"Nagy","year":"2019","journal-title":"Materials"},{"key":"10.1016\/j.bmc.2022.116855_b0180","doi-asserted-by":"crossref","unstructured":"G. Kardos, T. So\u00f3s Tether-Free Immobilized Bifunctional Squaramide Organocatalysts for Batch and Flow Reactions. Eur. J. Org. Chem. 2013, 2013, 4490\u20134494. https:\/\/doi.org\/10.1002\/EJOC.201300626.","DOI":"10.1002\/ejoc.201300626"},{"key":"10.1016\/j.bmc.2022.116855_b0185","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1039\/C8NJ06451B","article-title":"Kupai New enantiopure binaphthyl-cinchona thiosquaramides: synthesis and application for enantioselective organocatalysis","volume":"43","author":"Nagy","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.bmc.2022.116855_b0190","doi-asserted-by":"crossref","unstructured":"M. Rombola, V.H. Rawal Dicyclopentyl Dithiosquarate as an Intermediate for the Synthesis of Thiosquaramides. Org. Lett. 2018, 20, 514\u2013517. https:\/\/doi.org\/10.1021\/acs.orglett.7b03549.","DOI":"10.1021\/acs.orglett.7b03549"},{"key":"10.1016\/j.bmc.2022.116855_b0195","first-page":"2797","article-title":"Chauffert Cinchonine, a Potent Efflux Inhibitor to Circumvent Anthracycline Resistance In Vivo","volume":"52","author":"Genne","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.bmc.2022.116855_b0200","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00204-019-02417-6","article-title":"Szak\u00e1cs Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen","volume":"93","author":"Windt","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bmc.2022.116855_b0205","doi-asserted-by":"crossref","unstructured":"A.K. Ghose, V.N. Viswanadhan, J.J. Wendoloski A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J. Comb. Chem. 1999, 1, 55\u201368. https:\/\/doi.org\/10.1021\/cc9800071.","DOI":"10.1021\/cc9800071"},{"key":"10.1016\/j.bmc.2022.116855_b0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1158\/1535-7163.MCT-16-0333-T","article-title":"Szak\u00e1cs Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line-Specific Effects from P-Glycoprotein\u2013Induced Toxicity","volume":"16","author":"F\u00fcredi","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bmc.2022.116855_b0215","unstructured":"(accessed September 2021)https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00726414."},{"key":"10.1016\/j.bmc.2022.116855_b0220","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2125.1977.tb00760.x","article-title":"Salerno Comparison of quinidine plasma concentration curves following oral administration of some short- and long-acting formulations","volume":"4","author":"Frigo","year":"1977","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bmc.2022.116855_b0225","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1200\/JCO.1994.12.9.1771","article-title":"Leonard Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial","volume":"12","author":"Wishart","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bmc.2022.116855_b0230","first-page":"641","article-title":"Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome. Best Pract. Res","volume":"17","author":"Ross","year":"2004","journal-title":"Clin. Haematol."},{"key":"10.1016\/j.bmc.2022.116855_b0235","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1182\/blood.V88.4.1198.bloodjournal8841198","article-title":"Harousseau Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study","volume":"88","author":"Solary","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2022.116855_b0240","doi-asserted-by":"crossref","unstructured":"C.H. Keith, F.R. Maxfield, M.L. Shelanski Intracellular free calcium levels are reduced in mitotic Pt K2 epithelial cells. Proc. Natl. Acad. Sci. 1985, 82, 800\u2013804. https:\/\/doi.org\/10.1073\/PNAS.82.3.800.","DOI":"10.1073\/pnas.82.3.800"},{"key":"10.1016\/j.bmc.2022.116855_b0245","doi-asserted-by":"crossref","unstructured":"J.M. Tsangaris, T.A. Kabanos Circular dichroism of the complexes of quinine with copper(II), nickel(II), cobalt(II), chromium(III) and palladium(II) chlorides. Monatshefte F\u00fcr Chemie Chem. Mon. 1982, 113, 1393\u20131398. https:\/\/doi.org\/10.1007\/BF00808938.","DOI":"10.1007\/BF00808938"},{"key":"10.1016\/j.bmc.2022.116855_b0250","doi-asserted-by":"crossref","unstructured":"J.M. Tsangaris, G.T.H. Baxevanidis Complexes of Quinine with Cu(II), Ni(II), Co(II) and Cr(III) Chlorides. Zeitschrift Fur Naturforsch. - Sect. B J. Chem. Sci. 1974, 29, 532\u2013537. https:\/\/doi.org\/10.1515\/znb-1974-7-815.","DOI":"10.1515\/znb-1974-7-815"},{"key":"10.1016\/j.bmc.2022.116855_b0255","doi-asserted-by":"crossref","unstructured":"N.A. Rey, K.C. Dos Santos, M.\u00c2.B.C. Menezes, A.S. Mangrich, E.C. Pereira-Maia Two different modes for copper(II) ion coordination to quinine-type ligands. J. Braz. Chem. Soc. 2006, 17, 497\u2013504. https:\/\/doi.org\/10.1590\/S0103-50532006000300010.","DOI":"10.1590\/S0103-50532006000300010"},{"key":"10.1016\/j.bmc.2022.116855_b0260","doi-asserted-by":"crossref","unstructured":"U. Jungwirth, C.R. Kowol, B.K. Keppler, C.G. Hartinger, W. Berger, P. Heffeter Anticancer activity of metal complexes: Involvement of redox processes. Antioxidants Redox Signal. 2011, 15, 1085\u20131127. https:\/\/doi.org\/10.1089\/ars.2010.3663.","DOI":"10.1089\/ars.2010.3663"},{"key":"10.1016\/j.bmc.2022.116855_b0265","doi-asserted-by":"crossref","unstructured":"A.P. King, J.J. Wilson Endoplasmic reticulum stress: An arising target for metal-based anticancer agents. Chem. Soc. Rev. 2020, 49, 8113\u20138136. https:\/\/doi.org\/10.1039\/d0cs00259c.","DOI":"10.1039\/D0CS00259C"},{"key":"10.1016\/j.bmc.2022.116855_b0270","doi-asserted-by":"crossref","unstructured":"J.M. Myers, W.E. Antholine, J. Zielonka, C.R. Myers The iron-chelating drug triapine causes pronounced mitochondrial thiol redox stress. Toxicol. Lett. 2011, 201, 130\u2013136. https:\/\/doi.org\/10.1016\/j.toxlet.2010.12.017.","DOI":"10.1016\/j.toxlet.2010.12.017"},{"key":"10.1016\/j.bmc.2022.116855_b0275","first-page":"395","article-title":"Heffeter High Copper Complex Stability and Slow Reduction Kinetics as Key Parameters for Improved Activity, Paraptosis Induction, and Impact on Drug-Resistant Cells of Anticancer Thiosemicarbazones. Antioxidants Redox","volume":"33","author":"Hager","year":"2020","journal-title":"Signal."},{"key":"10.1016\/j.bmc.2022.116855_b0280","doi-asserted-by":"crossref","unstructured":"R.A. Finch, M.C. Liu, A.H. Cory, J.G. Cory, A.C. Sartorelli Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): An inhibitor of ribonucleotide reductase with antineoplastic activity. Adv. Enzym. Regul. 1999, 39, 3\u201312. https:\/\/doi.org\/10.1016\/S0065-2571(98)00017-X.","DOI":"10.1016\/S0065-2571(98)00017-X"},{"key":"10.1016\/j.bmc.2022.116855_b0285","unstructured":"(accesed September 2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02688101."},{"key":"10.1016\/j.bmc.2022.116855_b0290","doi-asserted-by":"crossref","unstructured":"L. Homolya, M. Holl\u00f3, M. M\u00fcller, E. Mechetner, B. Sarkadi A new method for quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells. Br. J. Cancer 1996 737 1996, 73, 849\u2013855. https:\/\/doi.org\/10.1038\/bjc.1996.151.","DOI":"10.1038\/bjc.1996.151"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622002474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622002474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:19:29Z","timestamp":1760836769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622002474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":58,"alternative-id":["S0968089622002474"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116855","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytotoxicity of cinchona alkaloid organocatalysts against MES-SA and MES-SA\/Dx5 multidrug-resistant uterine sarcoma cell lines","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116855"}}